Paricalcitol Capsule, Liquid Filled
NDC Package 49483-689-03
Package Information
Paricalcitol capsules is 1.1 Chronic Kidney Disease Stages 3 and 4Paricalcitol Capsules are indicated in adults for the prevention and treatment of secondary hyperparathyroidism associated with Chronic Kidney Disease (CKD) Stages 3 and 4. This formulation utilizes a capsule, liquid filled delivery system. Marketed by Time Cap Laboratories, Inc, this product is identified by NDC 49483-689 and is authorized under FDA application ANDA204948.
Identification & Billing
- RxCUI: 577315 - paricalcitol 1 MCG Oral Capsule
- RxCUI: 577315 - paricalcitol 0.001 MG Oral Capsule
- RxCUI: 577317 - paricalcitol 2 MCG Oral Capsule
- RxCUI: 577317 - paricalcitol 0.002 MG Oral Capsule
- RxCUI: 577324 - paricalcitol 4 MCG Oral Capsule
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 49483 - Time Cap Laboratories, Inc
- 49483-689 - Paricalcitol
- 49483-689-03 - 30 CAPSULE, LIQUID FILLED in 1 BOTTLE
- 49483-689 - Paricalcitol
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 49483-689-03 identifies a specific commercial package of 30 capsule, liquid filled in 1 bottle of Paricalcitol, a human prescription drug labeled by Time Cap Laboratories, Inc. This product is billed for "EA" each discreet unit and contains an estimated amount of 30 billable units per package. This capsule, liquid filled is formulated for oral use and contains paricalcitol as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Time Cap Laboratories, Inc on January 03, 2017. The current certification is valid through December 31, 2026.
How is this Time Cap Laboratories, Inc product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 49483068903. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 30 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.